Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Natural products and chronic hepatitis C virus.

Azzam HS, Goertz C, Fritts M, Jonas WB.

Liver Int. 2007 Feb;27(1):17-25. Review. Erratum in: Liver Int. 2007 Apr;27(3):421.

PMID:
17241377
2.

Hepatitis C virus virology and new treatment targets.

Meier V, Ramadori G.

Expert Rev Anti Infect Ther. 2009 Apr;7(3):329-50. doi: 10.1586/eri.09.12. Review.

PMID:
19344246
3.

A review of current anti-HCV treatment regimens and possible future strategies.

Neukam K, Macías J, Mira JA, Pineda JA.

Expert Opin Pharmacother. 2009 Feb;10(3):417-33. doi: 10.1517/14656560802694481 . Review.

PMID:
19191679
4.

Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues.

Brown NA.

Expert Opin Investig Drugs. 2009 Jun;18(6):709-25. doi: 10.1517/13543780902854194 . Review.

PMID:
19426125
5.

Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis.

Franchini M, Mengoli C, Veneri D, Mazzi R, Lippi G, Cruciani M.

J Antimicrob Chemother. 2008 Jun;61(6):1191-200. doi: 10.1093/jac/dkn119. Epub 2008 Mar 19. Review.

PMID:
18356154
6.

Bile acids promote the expression of hepatitis C virus in replicon-harboring cells.

Chang KO, George DW.

J Virol. 2007 Sep;81(18):9633-40. Epub 2007 Jul 3.

7.

Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.

Bautista D, Bermúdez-Silva FJ, Lasarte JJ, Rodriguez-Fonseca F, Baixeras E.

J Pathol. 2007 Nov;213(3):347-55.

PMID:
17940994
8.

Small molecule and novel treatments for chronic hepatitis C virus infection.

Harrison SA.

Am J Gastroenterol. 2007 Oct;102(10):2332-8. Epub 2007 Jul 7. Review.

PMID:
17617208
9.

Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study.

Posthouwer D, Yee TT, Makris M, Fischer K, Griffioen A, Van Veen JJ, Mauser-Bunschoten EP.

J Thromb Haemost. 2007 Aug;5(8):1624-9.

10.

Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials.

Fabrizi F, Bruchfeld A, Mangano S, Dixit V, Messa P, Martin P.

Int J Artif Organs. 2007 Mar;30(3):212-9. Review.

PMID:
17417760
11.

[Thrombocytopenia in HCV infection. Natural interferon as an alternative therapy].

Krzowska-Firych J, Modrzewska R, Kiciak SG.

Przegl Epidemiol. 2007;61(4):771-6. Review. Polish.

PMID:
18572510
12.

Current and future management of chronic hepatitis C infection.

Cross TJ, Antoniades CG, Harrison PM.

Postgrad Med J. 2008 Apr;84(990):172-6. doi: 10.1136/pgmj.2008.068205. Review.

PMID:
18424572
13.

Treatment of chronic hepatitis C virus infection - Dutch national guidelines.

de Bruijne J, Buster EH, Gelderblom HC, Brouwer JT, de Knegt RJ, van Erpecum KJ, Schalm SW, Bakker CM, Zaaijer HL, Janssen HL, Reesink HW; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):311-22. Review. Erratum in: Neth J Med. 2008 Dec;66(11):456. Dosage error in article text.

14.

Rapid virologic response: a new milestone in the management of chronic hepatitis C.

Poordad F, Reddy KR, Martin P.

Clin Infect Dis. 2008 Jan 1;46(1):78-84. doi: 10.1086/523585. Review.

PMID:
18171217
15.

Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.

Fabrizi F, Dixit V, Messa P, Martin P.

J Viral Hepat. 2008 Feb;15(2):79-88. doi: 10.1111/j.1365-2893.2007.00907.x.

PMID:
18184190
16.

Treatment of chronic hepatitis C virus infection among Brazilian haemophiliacs.

Pereira GH, Mangini C.

Braz J Infect Dis. 2008 Feb;12(1):20-3.

17.
18.

Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.

Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.

J Med Virol. 2007 Aug;79(8):1095-102.

PMID:
17597485
19.

Serine protease inhibitors as anti-hepatitis C virus agents.

Reiser M, Timm J.

Expert Rev Anti Infect Ther. 2009 Jun;7(5):537-47. doi: 10.1586/eri.09.30. Review.

PMID:
19485794
20.

New therapies for hepatitis C virus infection.

Soriano V, Peters MG, Zeuzem S.

Clin Infect Dis. 2009 Feb 1;48(3):313-20. doi: 10.1086/595848. Review.

PMID:
19123867

Supplemental Content

Support Center